Sex,Age at diagnosis,Final diagnosis,TOBACCO,Comorbidities,Radiological Pattern,Biopsy,Pathology pattern,Diagnosis after Biopsy,Antifibrotic Drug,Extrapulmonary affectation,Associated lung cancer,Other cancer,Blood count abnormality at diagnosis,Liver abnormality before diagnosis,Liver abnormality,FVC (%) at diagnosis,DLCO (%) at diagnosis,FVC (%) 1 year after diagnosis,DLCO (%) 1 year after diagnosis,RadioWorsening2y,1st degree relative,2nd degree relative,More than 1 relative,Mutation Type,Severity of telomere shortening,Anti-inflammatory drug,target,actual,predicted_probability
Female,73.0,1,0,1,UIP,0.0,0,-9.0,1,0.0,0.0,0.0,0.0,No,No,62.9,75.5,122.0,84.0,0.0,1,0,1,Not Investigated,1.0,0,0,0,0.17
Male,76.0,1,2,1,UIP,0.0,0,-9.0,0,0.0,0.0,0.0,0.0,No,No,96.0,82.0,96.0,82.0,0.0,0,0,0,Not Investigated,,0,0,0,0.02
Female,74.0,1,0,1,Probable UIP,1.0,Probable UIP,1.0,1,0.0,0.0,0.0,0.0,No,No,100.0,81.5,103.0,46.0,0.0,0,0,0,Not Investigated,,0,0,0,0.12
Male,58.0,5,2,0,Indeterminate UIP,,0,-9.0,0,0.0,0.0,0.0,,No,No,100.0,82.0,88.0,77.0,0.0,1,0,1,Yes,1.0,0,1,1,0.54
Male,63.0,6,2,0,Non UIP,0.0,0,-9.0,0,0.0,0.0,0.0,0.0,Yes,Yes,72.0,70.0,87.0,79.0,0.0,1,0,0,No,1.0,0,0,0,0.29
Female,79.0,6,0,1,Non UIP,0.0,CHP,-9.0,0,0.0,0.0,0.0,0.0,No,No,103.0,69.0,105.0,77.0,0.0,0,0,0,Not Investigated,,1,0,0,0.01
Male,76.0,1,0,1,UIP,0.0,0,-9.0,1,0.0,0.0,0.0,0.0,No,No,73.7,36.9,72.4,36.7,1.0,1,1,1,No,1.0,0,1,1,0.85
Male,70.0,6,2,1,Probable UIP,1.0,CHP,1.0,0,0.0,0.0,0.0,0.0,No,No,74.5,50.0,70.0,52.0,0.0,0,0,0,Not Investigated,,1,0,0,0.14
Female,70.0,2,0,0,Indeterminate UIP,0.0,0,-9.0,1,1.0,0.0,0.0,0.0,No,Yes,122.0,73.8,122.0,87.0,0.0,1,0,1,Yes,2.0,0,0,0,0.42
Male,67.0,1,2,1,UIP,0.0,0,-9.0,1,0.0,0.0,0.0,0.0,No,No,61.0,49.0,61.0,50.0,0.0,0,0,0,Not Investigated,4.0,0,0,0,0.45
Male,73.0,1,2,1,Probable UIP,0.0,0,-9.0,1,0.0,0.0,0.0,0.0,No,No,91.0,65.0,84.0,60.0,0.0,0,0,0,Not Investigated,,0,0,0,0.0
